Table 5.
Cox proportional hazards model of predictive factors for long-term outcome in non-AF HT patients
| HR | 95% CI | P-value | |
|---|---|---|---|
| Sex | 0.618 | 0.304–1.258 | 0.184 |
| Age | 1.020 | 0.985–1.057 | 0.256 |
| NIHSS on admission | 1.065 | 0.989–1.146 | 0.094 |
| Hypertension | 0.810 | 0.410–1.602 | 0.545 |
| Diabetes | 2.706 | 1.170–6.254 | 0.020 |
| CAD | 0.977 | 0.421–2.267 | 0.956 |
| PLT | |||
| T1 | 0.674 | 0.317–1.433 | 0.306 |
| T2 | 1.399 | 0.632–3.098 | 0.408 |
| T3 | Ref | ||
| MPV | 1.314 | 1.032–1.675 | 0.027 |
| FIB | 1.298 | 1.047–1.610 | 0.018 |
| Anticoagulant therapy | 0.875 | 0.427–1.794 | 0.716 |
| Antiplatelet therapy | 0.838 | 0.429–1.636 | 0.604 |
NOTE. CI, confidence interval; HR, hazard ratio; AF, atrial fibrillation; HT, hemorrhagic transformation; NIHSS, National Institute of Health Stroke Scale; CAD, coronary artery disease; PLT, platelet counts; MPV, mean platelet volume; FIB, fibrinogen